Antibody functional assays as measures of Fc receptor-mediated immunity to HIV - New technologies and their impact on the HIV vaccine field

Bruce D. Wines, Hugh Billings, Milla R Mclean, Stephen J. Kent, P. Mark Hogarth

Research output: Contribution to journalReview ArticleResearchpeer-review

16 Citations (Scopus)

Abstract

Background: There is now intense interest in the role of HIV-specific antibodies and the engagement of FcγR functions in the control and prevention of HIV infection. The analyses of the RV144 vaccine trial, natural progression cohorts, and macaque models all point to a role for Fc-dependent effector functions, such as cytotoxicity (ADCC) or phagocytosis (ADCP), in the control of HIV. However, reliable assays that can be reproducibly used across different laboratories to measure Fcdependent functions, such as antibody dependent cellular cytotoxicity (ADCC) are limited. Method: This brief review highlights the importance of Fc properties for immunity to HIV, particularly via FcγR diversity and function. We discuss assays used to study FcR mediated functions of HIV-specific Ab, including our recently developed novel cell-free ELISA using homo-dimeric FcγR ectodomains to detect functionally relevant viral antigen-specific antibodies. Results: The binding of these dimeric FcγR ectodomains, to closely spaced pairs of IgG Fc, mimics the engagement and cross-linking of Fc receptors by IgG opsonized virions or infected cells as the essential prerequisite to the induction of Ab-dependent effector functions. The dimeric FcγR ELISA reliably correlates with ADCC in patient responses to influenza. The assay is amenable to high throughput and could be standardized across laboratories. Conclusion: We propose the assay has broader implications for the evaluation of the quality of antibody responses in viral infections and for the rapid evaluation of responses in vaccine development campaigns for HIV and other viral infections.

Original languageEnglish
Pages (from-to)202-215
Number of pages14
JournalCurrent HIV Research
Volume15
Issue number3
DOIs
Publication statusPublished - 2017

Keywords

  • ADCC
  • ADCP
  • Antibodies
  • Fc receptors
  • HIV
  • IG
  • Natural killer cells
  • Vaccine

Cite this

@article{519135658388451fb6cabb68f5862e7c,
title = "Antibody functional assays as measures of Fc receptor-mediated immunity to HIV - New technologies and their impact on the HIV vaccine field",
abstract = "Background: There is now intense interest in the role of HIV-specific antibodies and the engagement of FcγR functions in the control and prevention of HIV infection. The analyses of the RV144 vaccine trial, natural progression cohorts, and macaque models all point to a role for Fc-dependent effector functions, such as cytotoxicity (ADCC) or phagocytosis (ADCP), in the control of HIV. However, reliable assays that can be reproducibly used across different laboratories to measure Fcdependent functions, such as antibody dependent cellular cytotoxicity (ADCC) are limited. Method: This brief review highlights the importance of Fc properties for immunity to HIV, particularly via FcγR diversity and function. We discuss assays used to study FcR mediated functions of HIV-specific Ab, including our recently developed novel cell-free ELISA using homo-dimeric FcγR ectodomains to detect functionally relevant viral antigen-specific antibodies. Results: The binding of these dimeric FcγR ectodomains, to closely spaced pairs of IgG Fc, mimics the engagement and cross-linking of Fc receptors by IgG opsonized virions or infected cells as the essential prerequisite to the induction of Ab-dependent effector functions. The dimeric FcγR ELISA reliably correlates with ADCC in patient responses to influenza. The assay is amenable to high throughput and could be standardized across laboratories. Conclusion: We propose the assay has broader implications for the evaluation of the quality of antibody responses in viral infections and for the rapid evaluation of responses in vaccine development campaigns for HIV and other viral infections.",
keywords = "ADCC, ADCP, Antibodies, Fc receptors, HIV, IG, Natural killer cells, Vaccine",
author = "Wines, {Bruce D.} and Hugh Billings and Mclean, {Milla R} and Kent, {Stephen J.} and Hogarth, {P. Mark}",
year = "2017",
doi = "10.2174/1570162X15666170320112247",
language = "English",
volume = "15",
pages = "202--215",
journal = "Current HIV Research",
issn = "1570-162X",
publisher = "Bentham Science Publishers",
number = "3",

}

Antibody functional assays as measures of Fc receptor-mediated immunity to HIV - New technologies and their impact on the HIV vaccine field. / Wines, Bruce D.; Billings, Hugh; Mclean, Milla R; Kent, Stephen J.; Hogarth, P. Mark.

In: Current HIV Research, Vol. 15, No. 3, 2017, p. 202-215.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Antibody functional assays as measures of Fc receptor-mediated immunity to HIV - New technologies and their impact on the HIV vaccine field

AU - Wines, Bruce D.

AU - Billings, Hugh

AU - Mclean, Milla R

AU - Kent, Stephen J.

AU - Hogarth, P. Mark

PY - 2017

Y1 - 2017

N2 - Background: There is now intense interest in the role of HIV-specific antibodies and the engagement of FcγR functions in the control and prevention of HIV infection. The analyses of the RV144 vaccine trial, natural progression cohorts, and macaque models all point to a role for Fc-dependent effector functions, such as cytotoxicity (ADCC) or phagocytosis (ADCP), in the control of HIV. However, reliable assays that can be reproducibly used across different laboratories to measure Fcdependent functions, such as antibody dependent cellular cytotoxicity (ADCC) are limited. Method: This brief review highlights the importance of Fc properties for immunity to HIV, particularly via FcγR diversity and function. We discuss assays used to study FcR mediated functions of HIV-specific Ab, including our recently developed novel cell-free ELISA using homo-dimeric FcγR ectodomains to detect functionally relevant viral antigen-specific antibodies. Results: The binding of these dimeric FcγR ectodomains, to closely spaced pairs of IgG Fc, mimics the engagement and cross-linking of Fc receptors by IgG opsonized virions or infected cells as the essential prerequisite to the induction of Ab-dependent effector functions. The dimeric FcγR ELISA reliably correlates with ADCC in patient responses to influenza. The assay is amenable to high throughput and could be standardized across laboratories. Conclusion: We propose the assay has broader implications for the evaluation of the quality of antibody responses in viral infections and for the rapid evaluation of responses in vaccine development campaigns for HIV and other viral infections.

AB - Background: There is now intense interest in the role of HIV-specific antibodies and the engagement of FcγR functions in the control and prevention of HIV infection. The analyses of the RV144 vaccine trial, natural progression cohorts, and macaque models all point to a role for Fc-dependent effector functions, such as cytotoxicity (ADCC) or phagocytosis (ADCP), in the control of HIV. However, reliable assays that can be reproducibly used across different laboratories to measure Fcdependent functions, such as antibody dependent cellular cytotoxicity (ADCC) are limited. Method: This brief review highlights the importance of Fc properties for immunity to HIV, particularly via FcγR diversity and function. We discuss assays used to study FcR mediated functions of HIV-specific Ab, including our recently developed novel cell-free ELISA using homo-dimeric FcγR ectodomains to detect functionally relevant viral antigen-specific antibodies. Results: The binding of these dimeric FcγR ectodomains, to closely spaced pairs of IgG Fc, mimics the engagement and cross-linking of Fc receptors by IgG opsonized virions or infected cells as the essential prerequisite to the induction of Ab-dependent effector functions. The dimeric FcγR ELISA reliably correlates with ADCC in patient responses to influenza. The assay is amenable to high throughput and could be standardized across laboratories. Conclusion: We propose the assay has broader implications for the evaluation of the quality of antibody responses in viral infections and for the rapid evaluation of responses in vaccine development campaigns for HIV and other viral infections.

KW - ADCC

KW - ADCP

KW - Antibodies

KW - Fc receptors

KW - HIV

KW - IG

KW - Natural killer cells

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85025082969&partnerID=8YFLogxK

U2 - 10.2174/1570162X15666170320112247

DO - 10.2174/1570162X15666170320112247

M3 - Review Article

VL - 15

SP - 202

EP - 215

JO - Current HIV Research

JF - Current HIV Research

SN - 1570-162X

IS - 3

ER -